title: The cutting edge: Thalidomide for type 1 cryoglobulinemic vasculopathy.
authors.affiliation: Division of Dermatology, Department of Medicine, University of Louisville School of Medicine, Louisville, KY, USA.
authors.forename: Alia
authors.initials: A
authors.lastname: Sampson
authors.forename: Jeffrey P
authors.initials: JP
authors.lastname: Callen
mesh_terms: D000284:Administration, Oral; D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D003449:Cryoglobulinemia / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D035002:Lower Extremity; D017445:Skin Diseases, Vascular / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D013792:Thalidomide / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide